Toll Free: (877) 796-6397 -- USA and Canada only -- |
Fax: +1-832-582-8590 Orders: +1-832-582-8158 |
Tech Support: +1-832-582-8158 Ext:3 Please provide your Order Number in the email. |
Formula | C16H16F3N3O3 |
|||
Molecular Weight | 355.31 | CAS No. | 1333151-73-7 | |
Solubility (25°C)* | In vitro | DMSO | 71 mg/mL (199.82 mM) | |
Ethanol | 71 mg/mL (199.82 mM) | |||
Water | Insoluble | |||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. * Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.) |
Description | KPT-185 is a selective CRM1 inhibitor that induces growth inhibition and apoptosis in a panel of NHL cell lines with a median IC50 ~25 nM. | |
---|---|---|
Targets |
|
|
In vitro | KPT-185 significantly inhibits leukemia cell proliferation with IC50 ranging from 100 nM to 500 nM, and induces cell-cycle arrest and apoptosis of AML cell lines and primary AML blasts. KPT-185 reduces CRM1 protein protein level and shows a significant nuclear accumulation of CRM1 cargo proteins. [1] KPT-185 also inhibits proliferation and promotes apoptosis of pancreatic cancer cells without affecting human pancreatic ductal epithelial cells. [2] |
Cell Assay: |
|
---|
|
Data from [Data independently produced by , , Biochem Biophys Res Commun, 2018, 503(3):1544-1549]
Discovery of compounds that reactivate p53 mutants in vitro and in vivo [ Cell Chem Biol, 2022, S2451-9456(22)00275-6] | PubMed: 35948006 |
Targeted CRM1-inhibition perturbs leukemogenic NUP214 fusion proteins and exerts anti-cancer effects in leukemia cell lines with NUP214 rearrangements [ Oncotarget, 2020, 11(36):3371-3386] | PubMed: 32934780 |
STK38 kinase acts as XPO1 gatekeeper regulating the nuclear export of autophagy proteins and other cargoes [ EMBO Rep, 2019, 20(11):e48150] | PubMed: 31544310 |
NEDD4 protects vascular endothelial cells against Angiotensin II-induced cell death via enhancement of XPO1-mediated nuclear export. [ Exp Cell Res, 2019, 10.1016/j.yexcr.2019.111505] | PubMed: 31326389 |
XPO1-mediated nuclear export of RNF146 protects from angiotensin II-induced endothelial cellular injury [Sheng Z Biochem Biophys Res Commun, 2018, 503(3):1544-1549] | PubMed: 30029878 |
EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer. [ Nat Commun, 2017, 8(1):2035] | PubMed: 29229958 |
Inhibiting PLK1 induces autophagy of acute myeloid leukemia cells via mammalian target of rapamycin pathway dephosphorylation. [Tao YF, et al. Oncol Rep, 2017, 37(3):1419-1429] | PubMed: 28184925 |
Activation of Yap-Directed Transcription by Knockdown of Conserved Cellular Functions. [ J Biomol Screen, 2016, 21(3):269-76] | PubMed: 26637552 |
RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.
NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.